Scienture (NASDAQ:SCNX) Announces Quarterly Earnings Results

Scienture (NASDAQ:SCNX) announced its quarterly earnings data on Wednesday. The company reported ($0.19) earnings per share (EPS) for the quarter, Zacks reports. The firm had revenue of $0.59 million for the quarter. Scienture had a negative return on equity of 24.47% and a negative net margin of 10,364.22%.

Scienture Price Performance

SCNX stock traded down $0.03 during trading on Friday, reaching $0.64. 2,042,600 shares of the company were exchanged, compared to its average volume of 7,119,188. The company has a market capitalization of $22.18 million, a price-to-earnings ratio of -0.24 and a beta of 3.04. The company has a debt-to-equity ratio of 0.02, a current ratio of 0.11 and a quick ratio of 0.11. The company has a 50-day moving average of $0.85 and a two-hundred day moving average of $1.14. Scienture has a twelve month low of $0.46 and a twelve month high of $8.72.

Analysts Set New Price Targets

SCNX has been the topic of several analyst reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Scienture in a research report on Wednesday, October 8th. Wall Street Zen downgraded Scienture from a “hold” rating to a “sell” rating in a report on Sunday, August 17th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, Scienture has an average rating of “Sell”.

About Scienture

Scienture Holdings, Inc engages in the provision of health services and pharmaceutical products. It focuses on addressing underserved patients and indications through novel product concepts and innovation. The company was founded on July 15, 2005 and is headquartered in Lutz, FL.